Popper and Company is an M&A advisory and specialty consulting firm serving life science and technology clients. Specific services include corporate strategy development, commercialization and regulatory strategy and implementation, partnering candidate identification and agreement negotiation. M&A advisory services include identification, prioritization and initiation of contact with potential acquirers and targets, valuation analyses, diligence, deal structuring and negotiation.
The principals have domain expertise in clinical practice, research, information technology, engineering, and finance, as well as broad hands-on operating experience in clinical diagnostics, medical devices and drug development. The firm also has particular expertise and interest in personalized medicine and biomarkers in clinical diagnostics and therapeutics contexts.
Popper and Company was founded in 2003. Its clients are private and public companies and investors in North America, Europe and Asia.
Specialties
Strategy, commercialization, M&A, licensing, regulatory, diagnostics, medical devices, mhealth, wellness, life sciences
